Anzeige
Mehr »
Dienstag, 30.12.2025 - Börsentäglich über 12.000 News
Insider-Alarm bei FUTR: Scott Paterson kauft wie ein Besessener!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
528 Leser
Artikel bewerten:
(2)

Genesis Research Group Announces Participation of CEO David W. Miller in New ITN Business Healthcare Program

Genesis Research Group Announces Participation of CEO
David W. Miller in New ITN Business Healthcare Program

  • Genesis Research Group, led by newly appointed CEO, David W. Miller, is spotlighted in June's launch of ITN Business' "Advancing Healthcare" program for its 'innovate differently' approach to supporting life sciences companies and accelerating patient access to optimal care.

Release date: 12 June 2024

Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, announces the participation of its CEO David W. Miller in an ITN Business program on advancing healthcare. The program highlights the company's Flexible Integrated Team (FIT) engagement model and provides insights into how such innovative approaches and advanced technology are boosting efficiencies and accelerating patient access to optimal care.

David W. Miller's interview by leading broadcaster Alice Beer will be showcased in Advancing Healthcare, set to premiere on 12 and 13 June 2024 at the NHS ConfedExpo in Manchester, UK. This insightful program delves into the future of healthcare through the lens of innovation, preventative thinking, data-driven health solutions, and collaborative efforts. Other leading industry figures featured include NHS Confederation CEO Matthew Taylor, NHS Supply Chain CEO Andrew New, and, in an extended edition from July, Susan Rienow, President of the Association of the British Pharmaceutical Industry (ABPI). The program, which features key industry and news-style reports along with sponsored editorial profiles, will showcase Genesis Research Group's innovative approach to agile, tech-enabled research partnerships and both its stakeholder insight platform, RPR, and its AI-powered evidence synthesis services.

David W. Miller, Chief Executive Officer of Genesis Research Group, said: "We are excited to have been invited to represent the essential work of research organizations, and to show how Genesis Research Group continues to innovate differently through our agile FIT engagement model and tech-enabled solutions. The program is an excellent platform on which to highlight our commitment to integrating innovation, stakeholder insights, and scientifically rigorous expertise to better inform decision-making and improve patient outcomes."

You can watch the program on Genesis Research Group's website at: www.genesisrg.com/ITN

-ENDS-

About Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise, and a revolutionary engagement model, they enable pharmaceutical, biotech, and medical device companies to anticipate and address the evolving evidence needs of payers, regulators, and stakeholders.

The company's tailored solutions encompass strategic guidance and scientifically rigorous real-world evidence, health economics and outcomes research, and market access solutions. With a vision to redefine healthcare research, they accelerate patient access to optimal care through unique insights and agile, technology-enabled research partnerships.

Powered by an innovative FIT engagement model, Genesis Research Group delivers dedicated, cross-functional teams that seamlessly integrate with client organizations and pivot quickly to meet changing research needs.

For more information, visit www.genesisrg.com

About ITN Business

Building on its decades of experience in B2B and corporate communications, ITN Business works with organizations, businesses, and brands to create a deeper, more authentic connection with their people, customers, partners, investors, or the wider world. Its broadcast news-style programming and bespoke digital campaigns for sectors, charities, and industries, share stories of innovation, best practice and thought leadership, to connect with the audiences that matter to its clients, and to ensure longer-term impact.

For more information visit: www.itn.co.uk/business

(Note to Editors: High-resolution images and additional information about the program and campaign are available upon request.)

For media enquiries

Genesis Research Group
Richard Chumbley
rchumbley@genesisrg.com

ICR Consilium
Amber Fennell, Angela Gray, Kris Lam
Tel: +44


© 2024 GlobeNewswire (Europe)
Gold & Silber auf Rekordjagd
Kaum eine Entwicklung war 2025 so eindrucksvoll wie der Höhenflug der Edelmetalle. Allen voran Silber: Angetrieben von einem strukturellen Angebotsdefizit, explodierte der Preis und übertrumpfte dabei den „großen Bruder“ Gold. Die Nachfrage aus dem Investmentsektor zieht weiter an, und ein Preisziel von 100 US-Dollar rückt in greifbare Nähe.

Auch Gold markierte neue Meilensteine. Mit dem Durchbruch über 3.000 und 4.000 US-Dollar pro Unze hat sich der übergeordnete Aufwärtstrend eindrucksvoll bestätigt. Rücksetzer bleiben möglich, doch der nächste Zielbereich bei 5.000 US-Dollar ist charttechnisch fest im Blick. Die fundamentalen Treiber sind intakt, eine nachhaltige Trendwende aktuell nicht in Sicht.

Für Anlegerinnen und Anleger bedeutet das: Jetzt ist die Zeit, um gezielt auf starke Produzenten zu setzen. In unserem neuen Spezialreport stellen wir fünf Gold- und Silberaktien vor, die trotz Rallye weiter attraktives Potenzial bieten, mit robusten Fundamentaldaten und starken Projekten in aussichtsreichen Regionen.

Jetzt den kostenlosen Report sichern und von der nächsten Welle im Edelmetall-Boom profitieren!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.